Case Report: A patient with the rare third-generation TKI-resistant mutation EGFR L718Q who responded to afatinib plus cetuximab combination therapy
Article in Frontiers in Oncology (October 2022)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (October 2022)
Article in Oncology Letters (September 2022)
Article in Reactions Weekly (September 2022)